SavedAdd your journal

Journals / Klinik Psikofarmakoloji Bülteni / 2014 / Cilt: 24 - Sayı: 4

Bir ergen olguda trikotilomaninin psikofarmakolojik tedavisi: Aripiprazol augmentasyonu ile belirgin iyileşme

Psychopharmacological treatment of trichotillomania in an adolescent case: Significant improvement with aripiprazole augmentation

Kemal Utku YAZICI
İpek PERÇİNEL
Pages
376–380
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here, we report the case of a 15-year-old adolescent with trichotillomania who responded to aripiprazole treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Trichotillomania (TTM) is a chronic impulse control disorder characterized by pulling out one s own hair, resulting in noticeable hair loss.
📊
Key Findings & Data:The emergence of TTM is generally in adolescence.
💡
Conclusion & Impact:Here, we report the case of a 15-year-old adolescent with trichotillomania who responded to aripiprazole treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Trichotillomania (TTM) is a chronic impulse control disorder characterized by pulling out one s own hair, resulting in noticeable hair loss. The emergence of TTM is generally in adolescence. A number of pharmacological agents and psychotherapy (especially cognitive-behavioral therapy) have been used in the treatment of TTM but in the literature, no consensus has yet been established. Here, we report the case of a 15-year-old adolescent with trichotillomania who responded to aripiprazole treatment.

Özet

Trikotilomani (TTM), kişinin saçını belirgin bir açıklık bırakacak şekilde koparmasıyla karakterize, kronik bir dürtü kontrol bozukluğudur. TTMnin başlangıç yaşı genellikle ergenlik döneminde olmaktadır. TTM tedavisinde, birçok farmakolojik ajan ve psikoterapi (özellikle bilişsel davranışcı terapi) yöntemleri kullanılmasına rağmen literatürde henüz bu konuyla ilgili bir görüş birliğine varılamadığı görülmektedir. Bu yazıda, trikotilomani semptomları aripiprazol tedavisine yanıt veren 15 yaşında bir ergen olgu bildirilmiştir.

🔖

Cite This Article

YAZICI, K. U., PERÇİNEL, İ. (2022). Bir ergen olguda trikotilomaninin psikofarmakolojik tedavisi: Aripiprazol augmentasyonu ile belirgin iyileşme. Klinik Psikofarmakoloji Bülteni, Cilt: 24 - Sayı: 4, 376–380. https://ajindex.com/articles/574033

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Swedo SE. Trichotillomania. Hollander E (Ed). Obsessive- Compulsive Related Disorders. Washington DC: American Psychiatric Press; 1993; p. 93-111
  2. Sadock VA, Sadock BJ (editors). Impulse-control disorders not elsewhere classified. Synopsis of Psychiatry. 9th edition. Philadelphia: Lippincot Williams& Wilkins; 2003; p. 790-2
  3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, fourth ed. Washington. DC: American Psychiatric Association, 1994
  4. Swedo SE, Leonard HL. Trichotillomania. An obsessive compulsive spectrum disorder? Psychiatr Clin North Am 1992; 15(4):777-90
  5. Zaimoğlu S. Dürtü Kontrol Bozuklukları. Çuhadaroğlu F, Coşkun A, Pehlivantürk B, İşeri E, Türkbay T, Miral S, Uslu R, Mukaddes NM, Ünal F, eds. Basic Book of Child and Adolescent Psychiatry. 1 st edition. Hekimler Yayın Birliği; 2008; s. 540-53
  6. Wright HH, Holmes GR. Trichotillomania (hair pulling) in toddlers. Psychol Rep 2003;92(1):228-30. [CrossRef] 7. Cohen LJ, Stein DJ, Simeon D, Spadaccini E, Rosen J, Aronowitz B, et al. Clinical profile, comorbidity, and treatment history in 123 hair pullers: A survey study. J Clin Psychiatry 1995;56(7):319-26
  7. Stanley MA, Breckenridge JK, Swann AC, Freeman EB, Reich L. Fluvoxamine treatment of trichotillomania. J Clin Psychopharmacol 1997;17(4):278-83. [CrossRef] 9. Konkan R, Şenormancı Ö, Sungur MZ. Diagnosis, pharmacotherapy and cognitive behavioral therapy of trichotillomania. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 2011;21(3):265-74. [CrossRef] 10. Potenza MN, Wasylink S, Epperson CN, McDougle CJ. Olanzapine augmentation of fluoxetine in the treatment of trichotillomania. Am J Psychiatry 1998;155(9):1299-1300
  8. Van Ameringen M, Mancini C, Oakman JM, Farvolden P. The potential role of haloperidol in the treatment of trichotillomania. J Affect Disord 1999;56(2-3):219-26. [CrossRef] 12. Sharma V, Corpse C. Lithium treatment of trichotillomania with comorbid bipolar II disorder. Arch Womens Ment Health 2008;11(4):305-6. [CrossRef] 13. Adewuya EC, Zinser W, Thomas C. Trichotillomania: a case of response to Valproic Acid. J Child Adolesc Psychopharmacol 2008;18(5):533-6. [CrossRef] 14. Lochner C, Seedat S, Niehaus DJH, Stein DJ. Topirmate in the treatment of trichotillomania: an open-label pilot study. Int Clin Psychopharmacol 2006;21(5):255-9. [CrossRef] 15. De Sousa A. An open-label pilot study of naltrexone in childhoodonset trichotillomania. J Child Adolesc Ps